These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24350634)

  • 21. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
    Raut Desai S; Rohera BD
    Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel swellable polymer of orchidaceae family for gastroretentive drug delivery of famotidine.
    Razavi M; Nyamathulla S; Karimian H; Noordin MI
    Drug Des Devel Ther; 2014; 8():1315-29. PubMed ID: 25246773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of design of experiments to optimizing novel gastroretentive drug delivery of simvastatin.
    Jagdale S; Kurhe P; Kuchekar B; Chabukswar A
    Curr Drug Deliv; 2013 Oct; 10(5):527-41. PubMed ID: 23607639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and in vitro/in vivo evaluation of famotidine hydrochloride bioadhesive sustained release suspension.
    Liu H; Dai J; He J; Xu Y; Kesse Firempong C; Feng Y; He H
    Pak J Pharm Sci; 2024 Mar; 37(2):405-416. PubMed ID: 38767108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and optimization of gastric floating drug delivery system using Central composite design and its biopharmaceutical evaluation.
    Meka VS; Thing LK; Gorajana A; Kolapalli VR
    Pak J Pharm Sci; 2015 Jul; 28(4):1373-87. PubMed ID: 26142528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and characterization of an expandable, gastroretentive system of carvedilol phosphate by 32 factorial design.
    Avachat AM; Patel KB; Rokade MS; Dash RR
    PDA J Pharm Sci Technol; 2011; 65(1):12-9. PubMed ID: 21414936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scintigraphic evaluation of the in vivo performance of dry-coated delayed-release tablets in humans.
    Kambayashi A; Sako K; Kondo H
    Eur J Pharm Biopharm; 2020 Jul; 152():116-122. PubMed ID: 32380166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Floating drug delivery of a locally acting H2-antagonist: an approach using an in situ gelling liquid formulation.
    Rohith G; Sridhar BK; Srinatha A
    Acta Pharm; 2009 Sep; 59(3):345-54. PubMed ID: 19819830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical study on the influence of a fixed-dose combination of famotidine with calcium carbonate and magnesium hydroxide on the bioavailability of famotidine.
    Zhai Q; Fu J; Huang X; Xu B; Yuan YZ; Jiang T; Rong ZX; Chen HZ
    Arzneimittelforschung; 2008; 58(11):581-4. PubMed ID: 19137909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Optimization of Methscopolamine Bromide Gastroretentive Floating Tablets Using 32 Factorial Design.
    Singh MP; Kumar M; Shankar R
    Drug Res (Stuttg); 2020 Dec; 70(12):576-582. PubMed ID: 32992345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma scintigraphic evaluation of floating gastroretentive tablets of metformin HCl using a combination of three natural polymers in rabbits.
    Razavi M; Karimian H; Yeong CH; Chung LY; Nyamathulla S; Noordin MI
    Drug Des Devel Ther; 2015; 9():4373-86. PubMed ID: 26273196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis.
    Good DJ; Hartley R; Mathias N; Crison J; Tirucherai G; Timmins P; Hussain M; Haddadin R; Koo O; Nikfar F; Fung NK
    Mol Pharm; 2015 Dec; 12(12):4434-44. PubMed ID: 26536519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taste masking microspheres for orally disintegrating tablets.
    Xu J; Bovet LL; Zhao K
    Int J Pharm; 2008 Jul; 359(1-2):63-9. PubMed ID: 18455893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Swellable and porous bilayer tablet for gastroretentive drug delivery: Preparation and in vitro-in vivo evaluation.
    Hwang KM; Nguyen TT; Seok SH; Jo HI; Cho CH; Hwang KM; Kim JY; Park CW; Rhee YS; Park ES
    Int J Pharm; 2019 Dec; 572():118783. PubMed ID: 31678393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation, Optimization, and In vivo Evaluation of Gastroretentive Drug Delivery System of Nifedipine for the Treatment of Preeclampsia.
    Karemore MN; Avari JG
    AAPS PharmSciTech; 2019 May; 20(5):200. PubMed ID: 31127399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ion-exchange complex of famotidine: sustained release and taste masking approach of stable liquid dosage form.
    Aman RM; Meshali MM; Abdelghani GM
    Drug Discov Ther; 2014 Dec; 8(6):268-75. PubMed ID: 25639307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroretentive delivery of rifampicin: in vitro mucoadhesion and in vivo gamma scintigraphy.
    Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
    Int J Pharm; 2011 Jun; 411(1-2):106-12. PubMed ID: 21458549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation.
    Kassem MA; Elmeshad AN; Fares AR
    Int J Pharm; 2014 Mar; 463(1):68-80. PubMed ID: 24412520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and evaluation of a gastroretentive dosage form of labetalol hydrochloride.
    Garse H; Vij M; Yamgar M; Kadam V; Hirlekar R
    Arch Pharm Res; 2010 Mar; 33(3):405-10. PubMed ID: 20361305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization studies on floating multiparticulate gastroretentive drug delivery system of famotidine.
    Gupta R; Pathak K
    Drug Dev Ind Pharm; 2008 Nov; 34(11):1201-8. PubMed ID: 18686085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.